Petros Pharmaceuticals (PTPI) Ownership - Who Owns Petros Pharmaceuticals?
Petros Pharmaceuticals (PTPI) Ownership Overview
- 33.82% Insiders
- 66.18% Public Companies and Individual Investors
The ownership structure of Petros Pharmaceuticals (PTPI) stock is a mix of institutional, retail, and individual investors. , 33.82% is owned by Insiders, and 66.18% is owned by Public Companies and Individual Investors.
The ownership structure of Petros Pharmaceuticals (PTPI) stock is a mix of institutional, retail, and individual investors. Approximately 66.18% of the company’s stock is owned by Institutional Investors, 33.82% is owned by Insiders
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Joshua Silverman | 8,790,450 | Insider | 20.75% | 96,695 |
| Bruce Bernstein | 3,762,334 | Insider | 8.88% | 41,386 |
| Fady Boctor | 894,986 | Insider | 2.11% | 9,845 |
| Wayne Remell Walker | 881,333 | Insider | 2.08% | 9,695 |
FAQ
What percentage of Petros Pharmaceuticals (PTPI) stock is held by retail investors?
According to the latest TipRanks data, approximately 66.18% of Petros Pharmaceuticals (PTPI) stock is held by retail investors.
Who owns the most shares of Petros Pharmaceuticals (PTPI)?
Joshua Silverman owns the most shares of Petros Pharmaceuticals (PTPI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.